6515--Cepheid GeneXpert Infinity 80-80

The Department of Veterans Affairs (VA) Veterans Health Administration, specifically Veterans Integrated Service Network 21, intends to award a sole-source firm-fixed-price contract for a GeneXpert Infinity 80-80 system, a microbiology rapid PCR singleplex testing instrument. The procurement targets a non-waived RT-PCR test analyzer capable of automated sample extraction, amplification, and detection for infectious diseases including SARS-CoV2, RSV, Influenza A/B, Mycobacterium tuberculosis, C. difficile, and MRSA. The system must have FDA approval, bench-side accessibility, random access testing capabilities, and a bi-directional bar-coded interface compatible with VA systems. Interested companies believing they can provide this specific system must submit their information to Brandy Gastinell at brandy.gastinell@va.gov by February 10, 2025, at 8:00 AM PST. The government maintains sole discretion on whether to compete the procurement based on responses received, and this notice is not a request for competitive quotes.

The contract opportunity is not designated with any specific set-aside, and Cepheid is identified as the intended sole-source provider for the GeneXpert Infinity 80-80 system. The procurement falls under NAICS code 334516 (Analytical Laboratory Instrument Manufacturing) with a size standard of 1,000 employees, and the place of performance will be the VA Palo Alto facility. The vendor will be required to provide comprehensive training, maintenance, and equipment repairs, with a mandatory 90% monthly equipment uptime requirement. While specific award values are not disclosed, the contract will cover the procurement of the instrument, associated services, and ongoing support. The system must be capable of testing multiple specimen types, including blood, sputum, stool, wound, and nasal/nasopharyngeal swabs, indicating a broad diagnostic application within the VA healthcare system.